KBIO COMPANY Inc. (KOSDAQ: 038530)
South Korea
· Delayed Price · Currency is KRW
263.00
+1.00 (0.38%)
Jan 22, 2025, 3:19 PM KST
KBIO COMPANY Revenue
KBIO COMPANY had revenue of 16.52B KRW in the quarter ending September 30, 2024, with 152.06% growth. This brings the company's revenue in the last twelve months to 58.32B, up 94.57% year-over-year. In the year 2023, KBIO COMPANY had annual revenue of 27.32B, down -12.22%.
Revenue (ttm)
58.32B
Revenue Growth
+94.57%
P/S Ratio
0.52
Revenue / Employee
1.77B
Employees
33
Market Cap
30.38B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 27.32B | -3.80B | -12.22% |
Dec 31, 2022 | 31.13B | 22.41B | 256.90% |
Dec 31, 2021 | 8.72B | 3.01B | 52.80% |
Dec 31, 2018 | 5.71B | 676.84M | 13.45% |
Dec 31, 2017 | 5.03B | -13.60B | -73.00% |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Dec 31, 2013 | Pro | Pro | Pro |
Dec 31, 2012 | Pro | Pro | Pro |
Dec 31, 2011 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Electronics | 292.86T |
SK hynix | 57.73T |
LG Energy Solution | 27.17T |
Samsung Biologics Co.,Ltd. | 4,364.39B |
Hyundai Motor Company | 170.28T |
Kia Corporation | 104.63T |
Celltrion | 2,876.25B |
KB Financial Group | 14.11T |